Osaic Holdings
XFOR icon

Osaic Holdings’s X4 Pharmaceuticals XFOR Stock Holding History

Osaic Holdings’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13
Closed -$268 – 7666
2024
Q3 		$268 Hold
13
– – ﹤0.01% 7129
2024
Q2 		$232 Buy
+13
New +$425 ﹤0.01% 7145
2023
Q2 		– Sell
-18
Closed -$460 – 7593
2023
Q1 		$460 Sell
18
-148
-89% -$4.34K ﹤0.01% 7147
2022
Q4 		$5K Hold
166
– – ﹤0.01% 6318
2022
Q3 		$9K Hold
166
– – ﹤0.01% 6080
2022
Q2 		$5K Buy
166
+136
+453% +$5.17K ﹤0.01% 6509
2022
Q1 		$117K Buy
30
+17
+131% +$975 ﹤0.01% 4469
2021
Q4 		$1K Hold
13
– – ﹤0.01% 7264
2021
Q3 		$2K Hold
13
– – ﹤0.01% 6897
2021
Q2 		$3K Hold
13
– – ﹤0.01% 6637
2021
Q1 		$3K Buy
+13
New +$3.42K ﹤0.01% 6414

Other funds holding XFOR

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Osaic Holdings's XFOR Position: Q4 2024 in Review

Osaic Holdings sold out of X4 Pharmaceuticals (XFOR) in Q4 2024, closing a stake of 13 shares — an estimated $268 sold.

Osaic Holdings first reported a position in XFOR in Q1 2021 and held it in 11 quarters. The position peaked at $117K in Q1 2022. 89 funds tracked by Wall St. Rank hold XFOR as of Q4 2024.

  • Osaic Holdings reported no remaining X4 Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Osaic Holdings sold 13 X4 Pharmaceuticals shares in Q4 2024, an estimated $268.
  • Osaic Holdings first reported a position in X4 Pharmaceuticals in Q1 2021 and held it in 11 quarters.
  • Osaic Holdings's X4 Pharmaceuticals position peaked at $117K in Q1 2022.
  • 89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q4 2024.

Based on Osaic Holdings's 13F filing for Q4 2024, filed 7 Feb 2025.